These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 342358)

  • 1. Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?
    Zieve L; Olsen RL
    Gut; 1977 Sep; 18(9):688-91. PubMed ID: 342358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of central action of octopamine.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy.
    Cuilleret G; Pomier-Layrargues G; Pons F; Cadilhac J; Michel H
    Gut; 1980 Jul; 21(7):565-9. PubMed ID: 6776015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of 3,4-dihydroxyphenylalanine and catecholamines and metabolites in brain in an anhepatic model of hepatic encephalopathy.
    Hadesman R; Wiesner RH; Go VL; Tyce GM
    J Neurochem; 1995 Sep; 65(3):1166-75. PubMed ID: 7643094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible modifications of neurotransmitters of the brain in experimental acute hepatic coma.
    Bloch P; Delorme ML; Rapin JR; Granger A; Boschat M; Opolon P
    Surg Gynecol Obstet; 1978 Apr; 146(4):551-8. PubMed ID: 24900
    [No Abstract]   [Full Text] [Related]  

  • 6. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy.
    Baraldi M; Zeneroli ML; Ricci P; Caselgrandi E; Ventura E
    Life Sci; 1983 Mar; 32(13):1417-25. PubMed ID: 6403789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral depression after intraventricular infusion of octopamine in rats.
    Chance WT; Bernardini AP; James JH; Edwards LL; Minnema K; Fischer JE
    Am J Surg; 1985 Nov; 150(5):577-84. PubMed ID: 2415012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of bromocriptine on brain levels of noradrenaline, dopamine and serotonin in experimental portosystemic encephalopathy].
    Arias J; Alsasua A; Estébanez E; López-Sánchez ML; Arias JI; García de Jalón PD; Durán Sacristán H
    Rev Clin Esp; 1983 Mar; 168(5):339-41. PubMed ID: 6867408
    [No Abstract]   [Full Text] [Related]  

  • 9. Depletion of brain norepinephrine in acute hepatic coma.
    Dodsworth JM; James JH; Cummings MC; Fischer JF
    Surgery; 1974 Jun; 75(6):811-20. PubMed ID: 4597290
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amphetamine derivatives on brain dopamine and noradrenaline.
    Breese GR; Kopin IJ; Weise VK
    Br J Pharmacol; 1970 May; 38(3):537-45. PubMed ID: 4909707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False neurotransmitters and hepatic coma.
    Fischer JE
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():53-73. PubMed ID: 4612663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of levodopa on brain levels of noradrenaline, dopamine and homovanillic acid in experimental portosystemic encephalopathy].
    Arias J; Alsasua A; Estebánez E; López-Sánchez ML; Arias JI; Durán M; García de Jalón PD; Durán Sacristán H
    Rev Clin Esp; 1982 Sep; 166(5):221-4. PubMed ID: 7146544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of biogenic amines in the central and peripheral nervous systems of rats with portacaval shunts, and their changes following administration of pargyline and levodopa].
    Alsasua A; Arias J; López-Sánchez ML; Estébanez E; Arias JI; García de Jalón PD; Durán Sacristán H
    Arch Farmacol Toxicol; 1982 Aug; 8(2):83-92. PubMed ID: 7159104
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelet uptake of octopamine and norepinephrine in hepatic encephalopathy.
    Morelli A; Frintzilas M; Zimmon DS
    Gastroenterology; 1977 Sep; 73(3):560-4. PubMed ID: 330303
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of octopamine on GABA-ergic transmission in rats.
    Jagiełło-Wójtowicz E; Chodkowska A
    Pol J Pharmacol Pharm; 1984; 36(6):595-601. PubMed ID: 6100132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain octopamine and strain differences in avoidance behavior.
    Delacour J; Coulon JF; David JC; Guenaire C
    Brain Res; 1983 Dec; 288(1-2):169-76. PubMed ID: 6419983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine and octopamine concentrations in brains of patients with Reye syndrome.
    Lloyd KG; Davidson L; Price K; McClung HJ; Gall DG
    Neurology; 1977 Oct; 27(10):985-8. PubMed ID: 333308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of central actions of intraventricularly administered octopamine, phenylethylamine and adrenaline in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1983; 35(1):59-62. PubMed ID: 6412221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenaline-octopamine interactions on cortical neurones in the rat.
    Jones RS
    Eur J Pharmacol; 1982 Jan; 77(2-3):159-62. PubMed ID: 6800831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.